ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Naringenin ameliorates postmenopausal osteoporosis by inhibiting BMSC oxidative stress via the PI3K/AKT/NRF2 pathway.

Yalong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.